EWSAT1
gene geneOn this page
Also known as FLJ33768
Summary
EWSAT1 (Ewing sarcoma associated transcript 1, HGNC:26596) is a long non-coding RNA gene on chromosome 15q23.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26596 |
| Approved symbol | EWSAT1 |
| Name | Ewing sarcoma associated transcript 1 |
| Location | 15q23 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | FLJ33768 |
| Ensembl gene | ENSG00000212766 |
| Ensembl biotype | lncRNA |
| OMIM | 616492 |
| Entrez | 283673 |
| RNAcentral | URS000075A2A2 — lncRNA, 2527 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 18 lncRNA
ENST00000415504, ENST00000435479, ENST00000440444, ENST00000558147, ENST00000558369, ENST00000558922, ENST00000559870, ENST00000559914, ENST00000559964, ENST00000822241, ENST00000822242, ENST00000822243, ENST00000822244, ENST00000822245, ENST00000822246, ENST00000822247, ENST00000822248, ENST00000822358
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000415504 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001599099 | 69094701 | 69095807 |
| ENSE00001637392 | 69074584 | 69074674 |
| ENSE00001660400 | 69091692 | 69092242 |
| ENSE00001716721 | 69072926 | 69073190 |
| ENSE00003596944 | 69090915 | 69091114 |
Expression profiles
Bgee: expression breadth ubiquitous, 149 present calls, max score 92.54.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2581 / max 45.7846, expressed in 64 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 147434 | 0.1840 | 39 |
| 147433 | 0.0435 | 14 |
| 147432 | 0.0239 | 3 |
| 147430 | 0.0041 | 2 |
| 147431 | 0.0027 | 2 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.54 | gold quality |
| sperm | CL:0000019 | 84.88 | gold quality |
| left testis | UBERON:0004533 | 83.49 | gold quality |
| right testis | UBERON:0004534 | 82.59 | gold quality |
| testis | UBERON:0000473 | 79.89 | gold quality |
| ileal mucosa | UBERON:0000331 | 78.52 | silver quality |
| right uterine tube | UBERON:0001302 | 77.79 | gold quality |
| tibialis anterior | UBERON:0001385 | 77.43 | silver quality |
| ganglionic eminence | UBERON:0004023 | 67.63 | gold quality |
| metanephros cortex | UBERON:0010533 | 66.16 | gold quality |
| pancreatic ductal cell | CL:0002079 | 65.44 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 64.76 | gold quality |
| cortical plate | UBERON:0005343 | 64.73 | gold quality |
| right adrenal gland | UBERON:0001233 | 64.60 | gold quality |
| adenohypophysis | UBERON:0002196 | 63.49 | gold quality |
| deltoid | UBERON:0001476 | 62.45 | gold quality |
| cerebellar vermis | UBERON:0004720 | 62.08 | silver quality |
| prefrontal cortex | UBERON:0000451 | 61.94 | gold quality |
| ventricular zone | UBERON:0003053 | 61.93 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.48 | gold quality |
| cortex of kidney | UBERON:0001225 | 60.63 | gold quality |
| nucleus accumbens | UBERON:0001882 | 60.60 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 60.57 | gold quality |
| cerebellar cortex | UBERON:0002129 | 60.45 | gold quality |
| pituitary gland | UBERON:0000007 | 60.32 | gold quality |
| hypothalamus | UBERON:0001898 | 60.29 | gold quality |
| left adrenal gland | UBERON:0001234 | 60.09 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 60.08 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 59.85 | gold quality |
| right frontal lobe | UBERON:0002810 | 59.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.42 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 9)
- data reveal that EWSAT1 is a downstream target of EWS-FLI1 that facilitates the development of Ewing sarcoma via the repression of target genes. (PMID:25401475)
- Collectively, our data revealed that EWSAT1 promotes nasopharyngeal carcinoma cell growth in vitro through up-regulating cyclin D1 partially via ‘spongeing’ miR-326/330-5p clusters. (PMID:27816050)
- EWSAT1 promotes osteosarcoma cell growth and metastasis through suppression of MEG3 expression. (PMID:27860482)
- HPV-positive cervical neoplasia patients exhibit significantly reduced LINC01101 and LINC00277 expression levels. (PMID:28767188)
- Increased EWSAT1 expression promotes cell proliferation, invasion and epithelial-mesenchymal transition in colorectal cancer cells. (PMID:30402843)
- LncRNA EWSAT1 upregulates CPEB4 via miR-330-5p to promote cervical cancer development. (PMID:32556917)
- EWSAT1 Acts in Concert with Exosomes in Osteosarcoma Progression and Tumor-Induced Angiogenesis: The ““Double Stacking Effect””. (PMID:32803878)
- LncRNA EWSAT1 Regulates the Tumorigenesis of NSCLC as a ceRNA by Modulating miR-330-5p/ITGA5 Axis. (PMID:33928467)
- LncRNA-EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the Src-YAP signaling axis. (PMID:36421017)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.